SpringerLink
Log in

Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Epstein-Barr virus (EBV) has been widely recognized to contribute to the development of nasopharyngeal carcinoma (NPC). The present study was to explore the association of plasma Epstein-Barr Virus LMP1 and EBER1 with circulating tumor cells (CTCs) and the metastasis of nasopharyngeal carcinoma. In the present study, we quantified the plasma levels of EBV DNA/RNAs, such as LMP1, LMP2, BART and EBER1 with real-time quantitative PCR, and CTCs with a CellSpotter Analyzer in NPC patients, with or without metastasis. Then the correlation of each biomarker with other biomarkers and tumor metastasis was analyzed. Our data indicated that the plasma levels of EBV LMP1, BART, EBER1, along with CTCs were significantly higher in metastatic NPC patients than in non-metastatic patients. Plasma LMP1 DNA and EBER1 discriminate metastatic NPC patients from non-metastatic patients, correlate with tumor stage and node stage for metastatic NPC patients. In summary, there were significantly higher plasma levels of Epstein-Barr Virus DNAs / RNAs in nasopharyngeal carcinoma patients. LMP1 DNA and EBER1 RNA correlated with the metastasis of nasopharyngeal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262

    Article  PubMed  Google Scholar 

  2. Chua M, Wee J, Hui EP, Chan A (2016) Nasopharyngeal carcinoma. Lancet 387:1012–1024. https://doi.org/10.1016/S0140-6736(15)00055-0

    Article  PubMed  Google Scholar 

  3. Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK (2018) Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 Oncogene among healthy population: an update. Front Oncol 8:211. https://doi.org/10.3389/fonc.2018.00211

    Article  PubMed  PubMed Central  Google Scholar 

  4. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693–698. https://doi.org/10.1056/NEJM199509143331103

    Article  CAS  PubMed  Google Scholar 

  5. Liebowitz D (1994) Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 21:376–381

    CAS  PubMed  Google Scholar 

  6. Tsao SW, Tsang CM, To KF, Lo KW (2015) The role of Epstein-Barr virus in epithelial malignancies. J Pathol 235:323–333. https://doi.org/10.1002/path.4448

    Article  CAS  PubMed  Google Scholar 

  7. Zou X, You R, Liu H et al (2017) Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment. Eur J Cancer 77:117–126. https://doi.org/10.1016/j.ejca.2017.02.029

    Article  PubMed  Google Scholar 

  8. Taylor GS, Blackbourn DJ (2011) Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett 305:263–278. https://doi.org/10.1016/j.canlet.2010.08.019

    Article  CAS  PubMed  Google Scholar 

  9. Young LS, Arrand JR, Murray PG (2007) EBV gene expression and regulation. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Chapter 27. Cambridge University Press, Cambridge

  10. Lin JC, Wang WY, Chen KY et al (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350:2461–2470. https://doi.org/10.1056/NEJMoa032260

    Article  CAS  PubMed  Google Scholar 

  11. Chan AT, Lo YM, Zee B et al (2002) Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94:1614–1619

    Article  CAS  PubMed  Google Scholar 

  12. Chan A, Hui EP, Ngan R et al (2018) Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal Cancer after Chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized controlled trial. J Clin Oncol: O2018777847. https://doi.org/10.1200/JCO.2018.77.7847

  13. Lin JC, Wang WY, Liang WM et al (2007) Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 68:1342–1348. https://doi.org/10.1016/j.ijrobp.2007.02.012

    Article  CAS  PubMed  Google Scholar 

  14. Pegtel DM, Middeldorp J, Thorley-Lawson DA (2004) Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 78:12613–12624. https://doi.org/10.1128/JVI.78.22.12613-12624.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hudnall SD, Ge Y, Wei L, Yang NP, Wang HQ, Chen T (2005) Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18:519–527. https://doi.org/10.1038/modpathol.3800369

    Article  PubMed  Google Scholar 

  16. Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M (2009) Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 83:7749–7760. https://doi.org/10.1128/JVI.00108-09

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tao Q, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF (1999) Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. Am J Pathol 155:619–625. https://doi.org/10.1016/S0002-9440(10)65157-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tong JH, Tsang RK, Lo KW et al (2002) Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 8:2612–2619

    CAS  PubMed  Google Scholar 

  19. Cosmopoulos K, Pegtel M, Hawkins J et al (2009) Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83:2357–2367. https://doi.org/10.1128/JVI.02104-08

    Article  CAS  PubMed  Google Scholar 

  20. Brooks L, Yao QY, Rickinson AB, Young LS (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689–2697

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Prayongrat A, Chakkabat C, Kannarunimit D, Hansasuta P, Lertbutsayanukul C (2017) Prevalence and significance of plasma Epstein-Barr virus DNA level in nasopharyngeal carcinoma. J Radiat Res 58:509–516. https://doi.org/10.1093/jrr/rrw128

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lertbutsayanukul C, Kannarunimit D, Prayongrat A, Chakkabat C, Kitpanit S, Hansasuta P (2018) Prognostic value of plasma EBV DNA for nasopharyngeal Cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy. Radiol Oncol 52:195–203. https://doi.org/10.2478/raon-2018-0016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kaye KM, Izumi KM, Mosialos G, Kieff E (1995) The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 69:675–683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549–560

    CAS  PubMed  Google Scholar 

  25. Turunen A, Rautava J, Grenman R, Syrjanen K, Syrjanen S (2017) Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget 8:27328–27338. https://doi.org/10.18632/oncotarget.16033

    Article  PubMed  Google Scholar 

  26. Chang Y, Cheng SD, Tsai CH (2002) Chromosomal integration of Epstein-Barr virus genomes in nasopharyngeal carcinoma cells. Head Neck 24:143–150

    Article  PubMed  Google Scholar 

  27. Kaschka-Dierich C, Adams A, Lindahl T et al (1976) Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature 260:302–306

    Article  CAS  PubMed  Google Scholar 

  28. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329–340. https://doi.org/10.1038/nrc2375

    Article  CAS  PubMed  Google Scholar 

  29. Lianidou ES, Markou A (2011) Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem 57:1242–1255. https://doi.org/10.1373/clinchem.2011.165068

    Article  CAS  PubMed  Google Scholar 

  30. Stevens SJ, Brink AA, Middeldorp JM (2005) Profiling of Epstein-Barr virus latent RNA expression in clinical specimens by gene-specific multiprimed cDNA synthesis and PCR. Methods Mol Biol 292:27–38

    CAS  PubMed  Google Scholar 

  31. Pavlovitch JH, Didierjean L, Rizk M, Balsan S, Saurat JH (1983) Skin calcium-binding protein: distribution in other tissues. Am J Phys 244:C50–C57. https://doi.org/10.1152/ajpcell.1983.244.1.C50

    Article  CAS  Google Scholar 

  32. Ramayanti O, Juwana H, Verkuijlen SA et al (2017) Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Int J Cancer 140:149–162. https://doi.org/10.1002/ijc.30418

    Article  CAS  PubMed  Google Scholar 

  33. Xu YJ, Zhou R, Zong JF et al (2019) Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-kappaB pathway. Cancer Lett 447:33–40. https://doi.org/10.1016/j.canlet.2019.01.022

    Article  CAS  PubMed  Google Scholar 

  34. Zuo LL, Zhang J, Liu LZ et al (2017) Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma. Oncogenesis 6:402. https://doi.org/10.1038/s41389-017-0005-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Huang D, Song SJ, Wu ZZ et al (2017) Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Res 77:3591–3604. https://doi.org/10.1158/0008-5472.CAN-16-2706

    Article  CAS  PubMed  Google Scholar 

  36. **e XQ, Luo Y, Ma XL et al (2019) Clinical significance of circulating tumor cells and their expression of cyclooxygenase-2 in patients with nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci 23:6951–6961. https://doi.org/10.26355/eurrev_201908_18735

    Article  PubMed  Google Scholar 

  37. Lee SW, Chen YW, Kuan EC, Lan MY (2019) Dual-function nanostructured platform for isolation of nasopharyngeal carcinoma circulating tumor cells and EBV DNA detection. Biosens Bioelectron 142:111509. https://doi.org/10.1016/j.bios.2019.111509

    Article  CAS  PubMed  Google Scholar 

  38. You R, Liu YP, Lin M et al (2019) Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients. Int J Cancer 145:2873–2883. https://doi.org/10.1002/ijc.32380

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was performed in First Hospital of Jilin University, Changchun, China.

Funding

The present study was supported by the grant from Jilin Province Science and Technology Development Plan (20160101051JC).

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Head & Neck Surgery, First Hospital of Jilin University, 71#, **nmin Street, Changchun, 130021, People’s Republic of China

    Le Sun, Yusheng Wang, **feng Shi, Wei Zhu & **n Wang

Authors
  1. Le Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yusheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. **feng Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. **n Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wei Zhu or **n Wang.

Ethics declarations

Conflict of Interests

The Authors declare that they have no conflict of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, L., Wang, Y., Shi, J. et al. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma. Pathol. Oncol. Res. 26, 1893–1901 (2020). https://doi.org/10.1007/s12253-019-00777-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-019-00777-z

Keywords

Search

Navigation